The Global Remdesivir Market is estimated to exhibit a CAGR of 7.11% during the forecast period of 2021-2028. The remdesivir market is majorly driven by the rapidly increasing need for a drug that can be used for the treatment of patient with severe COVID-19 symptoms. Rising cases of other viral diseases is also fostering the market growth in this region. However, high cost of remdesivir is expected to obstruct the growth of the remdesivir market.
Global Remdesivir Market Scenario
According to Data Bridge Market Research, the remdesivir market will exhibit a significant rise in its market value. The high investment in research and development to examine for the further uses of remdesivir and will further accelerate the expansion of the remdesivir market. Additionally, the easy availability and affordability to both government and citizens of the economy is further responsible for the development of remdesivir market. Moreover, rising research and development investment is also lifting the growth of the remdesivir market.
Currently, North America dominates the global remdesivir market in terms of market share and market revenue wherein U.S.A has emerged to be the major contributor owing to the rapidly rising cases of covid-19, high prevalence of diseases, easy availability, and strong presence of leading market players in this region.
Now the question is which are the other regions that the global remdesivir market is targeting? Data Bridge Market Research has estimated a large growth in Asia-Pacific owing to the high frequencies of viral disease outburst and conceding of authorization to manufacture remdesivir by the parent company within this region.
For more analysis on the global remdesivir market request for a briefing with our analysts https://www.databridgemarketresearch.com/fr/speak-to-analyst/?dbmr=global-remdesivir-market
Scope of the Remdesivir Market
The global remdesivir market is segmented on the basis of countries into U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
- The global remdesivir market is further segmented on the basis of dosage into 2.5mg, 5mg, 100mg and 200mg. Based on patient type, the remdesivir market is segmented into adult, pediatric and geriatric. On the basis of form, the remdesivir market is segmented into lyophilized powder and concentrated solution. Based on application, the remdesivir market is segmented into ebola, SARS-COV, MERS-COV and COVID-19. COVID-19 has further been segmented into invasive mechanical ventilation and non-Invasive mechanical ventilation. The end users segment of the remdesivir market is segmented into hospitals, clinics, pharmacy and drug stores and online pharmacies.
- Remdesivir is an antiviral medication developed by a pharmaceutical company named Gilead Sciences. Injected into the veins, it was the first drug approved by FDA.
To know more about the study https://www.databridgemarketresearch.com/fr/reports/global-remdesivir-market
Key Pointers Covered in the Remdesivir Market Industry Trends and Forecast to 2028
- Market Size
- Market New Sales Volumes
- Market Replacement Sales Volumes
- Market By Brands
- Market Procedure Volumes
- Market Product Price Analysis
- Regulatory Framework and Changes
- Prices and Reimbursement Analysis
- Market Shares in Different Regions
- Recent Developments for Market Competitors
Key Market Competitors Covered in the Remdesivir Market report
- Gilead Sciences, Inc.
- BrightGene Bio-Medical Technology Co., Ltd.
- Saptagir Laboratories Pvt. Ltd.
- Ferozsons Laboratories Limited
- Mylan N.V.
- Hovione
- Syngene
- EVA PHARM
- Zydus Cadila.
- Pfizer Inc.
- Dr. Reddy’s Laboratories Ltd.
- Biocon
- Hikma Pharmaceuticals PLC
- Beximco Pharmaceuticals Ltd.
- Hunan Warrant Chiral Pharmaceutical Co., Ltd.
- Hetero
- Everest Organics Limited
- PI & PI BOITECH INC
- Cipla Inc.
- Jubilant Life Sciences Limited
Above are the key players covered in the report, to know about more and exhaustive list of remdesivir market companies contact us https://www.databridgemarketresearch.com/fr/toc/?dbmr=global-remdesivir-market
Research Methodology: Global Remdesivir Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Related Reports
- Global Injectable Drug Delivery Market - Industry Trends and Forecast to 2025
- Global Drug Screening Market - Industry Trends and Forecast to 2028
- Global Ophthalmology Drugs and Devices Market - Industry Trends and Forecast to 2027
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/fr/report-category/healthcare/
